Top Markets
Coin of the day
Kindstar Globalgene Technology, Inc. Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc.

9960
Rank in Stocks #20805
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly... Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and pharmaceutical firms. This broad service portfolio is underpinned by its extensive, state-of-the-art laboratory infrastructure, which encompasses disciplines such as flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, and microbiology, alongside dedicated scientific research labs. Kindstar Global offers a comprehensive range of diagnostic tests covering key areas like hematology (blood), oncology (tumor), and genetic disorders. Its capabilities also extend to diseases affecting the cardiovascular and cerebrovascular systems, infectious agents, and autoimmune conditions, supporting various medical specialties including internal medicine, surgery, gynecology, pediatrics, and numerous other clinical fields. Established in 2003, the company maintains its headquarters in Wuhan, China.
Share Price
$0.11769213
Market Cap
$121.61M
Change (1 day)
-0.54%
Change (1 year)
-45.26%
Country
CN
Trade Kindstar Globalgene Technology, Inc. (9960)

Category

Revenue for Kindstar Globalgene Technology, Inc. (9960)
Revenue in Aug 2026 TTM: 0
According to Kindstar Globalgene Technology, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kindstar Globalgene Technology, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$7.23B -
US